The Changing Landscape of Pulmonary Hypertension Therapeutics


Dr. Mardi Gomberg-Maitland, associate professor of medicine and director of the pulmonary hypertension program at The University of Chicago Medicine, discusses PAH therapeutic trials, new drugs targeting known pathways and new delivery systems and resurgence of interventional methods.  Dr. Gomberg-Maitland also examines risk assessment, biomarkers and pharmacogenomics.   



Mardi Gomberg-Maitland

Mardi Gomberg-Maitland, MD

Associate Professor of Medicine

Admissions, Referrals and Consultations:

Call UCM Physician Connect at
Contact Us

Sign Up for Email Newsletters

Learn more >